ONCOLYTICS BIOTECH INC — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
Form 8-K filed 2026-11-20 (period 2026-11-19) disclosing Item 5.07 — Submission of Matters to a Vote of Security Holders. No specific vote details, counterparties, dollar amounts, percentages, share counts, or outcomes are provided in the filing header or document summary. The filing appears to be a standard procedural disclosure with substantive information not accessible from the metadata provided.
Why this rating
Routine voting disclosure; no material financial, operational, or strategic details disclosed. Insufficient information to assess business impact.
Extracted items
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.